CIK 0000949858
- Non-accelerated filer
- Smaller reporting company
ACHIEVE LIFE SCIENCES, INC.
Sign in to watch- Tickers
- ACHV QUIT
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 954343413
- Phone
- +1 425-686-1500
- Business address
- 22722 29TH DR. SE, SUITE 100, SEATTLE, WA, 98021
- Former names
- ONCOGENEX PHARMACEUTICALS, INC., SONUS PHARMACEUTICALS INC
Securities
- ACHV Common stock Nasdaq
- QUIT Common Shares Nasdaq
- DEF 14A Proxy Proxy Statement
- DEF 14A Proxy Proxy Statement
- PRE 14A Proxy Proxy Statement (Preliminary)
- DEF 14A Proxy Proxy Statement
- DEF 14A Proxy Proxy Statement
- DEF 14A Proxy Proxy Statement
- PRE 14A Proxy Proxy Statement (Preliminary)
- DEF 14A Proxy Proxy Statement
- DEF 14A Proxy Proxy Statement
- DEF 14A Proxy Proxy Statement
- DEF 14A Proxy Proxy Statement
- DEF 14A Proxy Proxy Statement
- PRE 14A Proxy Proxy Statement (Preliminary)
- DEF 14A Proxy Proxy Statement
- DEF 14A Proxy Proxy Statement
- DEF 14A Proxy Proxy Statement
- DEF 14A Proxy Proxy Statement
- DEF 14A Proxy Proxy Statement
- DEF 14A Proxy Proxy Statement
- DEF 14A Proxy Proxy Statement
Page 2 of 2 · 40 filings